Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?

• Yohei Hamada,

  Affiliation AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

  ⨯
• Takeshi Nishijima,

  Affiliations AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, Center for AIDS Research, Kumamoto University, Kumamoto, Japan

  ⨯
• Hirokazu Komatsu,

  Affiliation Department of Community Care, Saku Central Hospital, Nagano, Japan

  ⨯
• Katsuji Teruya,

  Affiliation AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

  ⨯
• Hiroyuki Gatanaga ,

  * E-mail: higatana@acc.ncgm.go.jp

  Affiliations AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, Center for AIDS Research, Kumamoto University, Kumamoto, Japan

  ⨯
• Yoshimi Kikuchi,

  Affiliation AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

  ⨯
• Shinichi Oka

  Affiliations AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, Center for AIDS Research, Kumamoto University, Kumamoto, Japan

  ⨯